Abingdon Health Plc (ABDX) - Total Liabilities
Based on the latest financial reports, Abingdon Health Plc (ABDX) has total liabilities worth GBX4.25 Million GBX (≈ $517.35 USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See how liquid is Abingdon Health Plc's working capital to evaluate short-term liquidity relative to the company's equity base.
Abingdon Health Plc - Total Liabilities Trend (2016–2025)
This chart illustrates how Abingdon Health Plc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Abingdon Health Plc assets under control.
Abingdon Health Plc Competitors by Total Liabilities
The table below lists competitors of Abingdon Health Plc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ortivus AB ser. A
ST:ORTI-A
|
Sweden | Skr47.71 Million |
|
Dewhurst plc
LSE:DWHA
|
UK | GBX10.81 Million |
|
Sanco Industries Limited
NSE:SANCO
|
India | Rs687.89 Million |
|
Mitra Komunikasi Nusantara Tbk PT
JK:MKNT
|
Indonesia | Rp835.11 Billion |
|
Desarrolladora Homex S.A.B. de C.V
MX:HOMEX
|
Mexico | MX$1.00 Billion |
|
GO.D.M Investments Ltd
TA:GODM
|
Israel | ILA165.00K |
|
Portmeirion Group PLC
LSE:PMP
|
UK | GBX48.98 Million |
|
Carclo plc
LSE:CAR
|
UK | GBX101.03 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down Abingdon Health Plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See ABDX equity financing ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.91 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.67 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Abingdon Health Plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Abingdon Health Plc (2016–2025)
The table below shows the annual total liabilities of Abingdon Health Plc from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | GBX4.01 Million ≈ $488.27 |
+41.25% |
| 2024-06-30 | GBX2.84 Million ≈ $345.67 |
-6.91% |
| 2023-06-30 | GBX3.05 Million ≈ $371.34 |
-51.85% |
| 2022-06-30 | GBX6.34 Million ≈ $771.27 |
-46.73% |
| 2021-06-30 | GBX11.90 Million ≈ $1.45K |
+44.79% |
| 2020-06-30 | GBX8.22 Million ≈ $1.00K |
+562.01% |
| 2019-06-30 | GBX1.24 Million ≈ $151.06 |
+11.95% |
| 2018-06-30 | GBX1.11 Million ≈ $134.93 |
-87.28% |
| 2016-12-31 | GBX8.72 Million ≈ $1.06K |
-- |
About Abingdon Health Plc
Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturing, Product Sales, and Regulatory segments. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant heal… Read more